期刊文献+

药物相关基因多态型与药代动力学相关性的研究进展 被引量:2

下载PDF
导出
摘要 药物代谢酶基因突变导致酶活性降低或失活,影响药物的氧化代谢。药物相关基因多态性是造成个体之间药代动力学差异的重要原因,如P450酶系的CYP2D6、CYP2C9、CYP2C19等和Ⅱ相代谢酶及药物转运蛋白的基因突变,使它们代谢药物的动力学参数发生巨大差异。通过对基因多态性与药动学关系的研究,可避免因受试者选择不当而得到片面的药动学结果,导致有前途的化合物被淘汰或使不合适的化合物上市成为新药,造成对患者的潜在危险。
作者 许景峰 米丽
出处 《解放军药学学报》 CAS 2009年第5期432-435,共4页 Pharmaceutical Journal of Chinese People's Liberation Army
  • 相关文献

参考文献19

二级参考文献65

  • 1王红,聂玉强,戴寿军,佘庆珠,李瑜元.质子泵抑制剂抑酸效果与肝药酶基因型的关系[J].中华内科杂志,2003,42(11):777-780. 被引量:5
  • 2楼雅卿,赵莉,张远.中国健康志愿者的奥美拉唑及其代谢物的药代动力学研究[J].中国临床药理学杂志,1994,10(1):14-21. 被引量:27
  • 3李云,吴寿岭,高润芝,王黎光,李东贤,刘克俭,侯国盛,周永.氢氯噻嗪对不同血管紧张素转化酶基因型高血压患者血浆血管紧张素转化酶血管紧张素Ⅱ浓度的影响[J].临床心血管病杂志,2005,21(7):405-407. 被引量:10
  • 4UMIT Y,STEFAN L,ERIK E,et al. Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms [ J ]. Biochem Biophys Res Commun, 2002,299( 1 ) :25 -28.
  • 5IMAI J, IEIRI K,MAMIYA K,et al. Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients: Genetic analysis of the CYP2C9 locus[ J]. Pharmacogenetics,2000, 10(2) :85 -89.
  • 6GAEDIG KA, CASLEY WL, TYNDALE RF, et al. Cytochrome P4502C9 (CYP2Cg) allele frequencies in Canadian native Indians and inuit populations [ J]. Can J Pharmacal, 2001,79 ( 10 ) : 841 - 847.
  • 7KIDD RS, CURRY TB, BLAISDELL J,et al. Identification of a nullallele of CYP2C9 in an African-American exhibiting toxicity to phenytoin [ J ]. Pharmacogenetics,2001,11 (9) : 803 - 808.
  • 8YASAR U,TYBRING G,HIDESTRAND M,et al. Role of CYP2C9 polymorphism in losartan oxidation [ J]. Drug Metab Dispos,2001,29(7) :1051 - 1056.
  • 9LONDON SJ, SULLIVAN-KLOSE T, DALY AK,et al. Lung cancer in relation to the CYP2C9 genetic polymorphism among Caucasians in Los Angeles County[ J]. Pharmacogenetics, 1997,7 (7) :401 -404.
  • 10GARCIA-MARTIN E,MARTINEZ C, LADERO G,et al. Influence of cytochrome P450 CYP2C9 genotypes in lung cancer risk [ J ]. Cancer Lett, 2002,180 ( 1 ) :41 - 46.

共引文献86

同被引文献33

  • 1杨功焕,马杰民,刘娜,周灵妮.中国人群2002年吸烟和被动吸烟的现状调查[J].中华流行病学杂志,2005,26(2):77-83. 被引量:1054
  • 2林学壬,徐立.雷贝拉唑与兰索拉唑治疗幽门螺杆菌阳性十二指肠溃疡的对比[J].中国医院药学杂志,2005,25(11):1054-1056. 被引量:8
  • 3王亚平,邹定全,江兴华,常业恬.麻醉药及镇痛药的药物基因组学[J].中华麻醉学杂志,2006,26(8):764-767. 被引量:5
  • 4Inoue M,Okada H, Hori S, et al. Dose pretreatment with lan- soprazole influence Helicobacter pylori eradication rate and quality of life? [J]. Digestion,2010,81 (4):218-222.
  • 5Miura M, Inoue K, Satoh S,et al. Influence of cytochrome P450 (CYP) 3A5 polymorphisms on the pharmacokinetics of lanso- prazole enantiomers in CYP2C19 extensive metaboliser renal transplant recipients[J]. Clin Drug Investig, 20/17,27 (4) : 251- 258.
  • 6Chen Q,Zhang T,Wang JF. Advances in human cytochrome P450 and personalized medicine[J].Current Drug Metabolism,2011,(05):436-444.
  • 7Andersson T,Flockhart DA,Goldstein DB. Drug-metabolizing enzymes:evidence for clinicalutility of pharmacogenomic tests[J].Clinical Pharmacology and Therapeutics,2005.559-581.
  • 8Raimundo S,Toscano C,Klein K. A novel intronic mutation 2988G-A,with high predictivity for impaired function of cytochrome P4502D6 in white[J].Clin Pharmacol Thr,2004.128-138.
  • 9Klein K,Tatzel S,Raimundo S. Short communication:a natural variant of the Heme-Binding signature(R441C)resulting in complete loss of function of CYP2D6[J].Drug Metabolism and Disposition,2007.1247-1250.
  • 10Kubota T,Yamaura Y,Ohkawa N. Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan odemethylation in different CYP2D6 genotypes[J].British Journal of Clinical Pharmacology,2000.31-34.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部